Related Experiment Video

Updated: Jul 19, 2026

Three Strategies to Induce Neurotrophic Keratitis and Nerve Regeneration in Murine Cornea
06:10

Three Strategies to Induce Neurotrophic Keratitis and Nerve Regeneration in Murine Cornea

Published on: December 8, 2023

Erythropoietin protects sensory axons against paclitaxel-induced distal degeneration

Giorgia Melli1, Christelene Jack, George L Lambrinos

  • 1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Neurobiology of Disease
|October 3, 2006
PubMed

Insights

Recombinant human erythropoietin (EPO) prevents nerve damage caused by paclitaxel, a chemotherapy drug. EPO therapy may help prevent chemotherapy-induced sensory polyneuropathy in patients.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Oncology

Background:

  • Paclitaxel chemotherapy can cause sensory polyneuropathy, characterized by distal axonal degeneration.
  • The precise mechanisms of paclitaxel-induced axonal degeneration are not fully understood but are linked to increased detyrosinated tubulin.

Purpose of the Study:

  • To investigate the neuroprotective effects of recombinant human erythropoietin (EPO) against paclitaxel-induced axonal degeneration.
  • To determine if EPO influences detyrosinated tubulin levels in sensory neurons.

Main Methods:

  • In vitro studies using sensory neurons exposed to paclitaxel.
  • In vivo studies using an animal model of paclitaxel-induced distal sensory polyneuropathy.
  • Assessment of axonal degeneration and detyrosinated tubulin levels.

Main Results:

  • Recombinant human EPO demonstrated a protective effect against axonal degeneration in sensory neurons in vitro.
  • EPO treatment was associated with a downregulation of detyrosinated tubulin.
  • In an animal model, EPO significantly protected against distal axonal degeneration induced by paclitaxel.

Conclusions:

  • Recombinant human EPO shows potential as a therapeutic agent to prevent paclitaxel-induced sensory polyneuropathy.
  • EPO's mechanism may involve the modulation of detyrosinated tubulin.
  • Further clinical investigation is warranted to evaluate EPO for chemotherapy-induced nerve damage.

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...